ArticleCPT: pharmacometrics & systems pharmacology2025

A Model-Based Approach to Evaluate Anti-Drug Antibody Impact on Drug Exposure With Biologics: A Case Example With the CD3 T-Cell Bispecific Cibisatamab.

Javier Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.